{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T03:04:31Z","timestamp":1780455871910,"version":"3.54.1"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Critical Care"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jcrc.2026.155558","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T16:41:29Z","timestamp":1775752889000},"page":"155558","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The association between interleukin-6 inhibitors as treatment for COVID-19 and mental health problems in ICU survivors"],"prefix":"10.1016","volume":"94","author":[{"given":"Thomas G.","family":"van Gelder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arief","family":"Lalmohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toine C.G.","family":"Egberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjen J.C.","family":"Slooter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke","family":"Zegers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"van den Boogaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene J.","family":"van Diem-Zaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcrc.2026.155558_bb0005","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1097\/CCM.0000000000000882","article-title":"Posttraumatic stress disorder in critical illness survivors: a metaanalysis","volume":"43","author":"Parker","year":"2015","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2026.155558_bb0010","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.genhosppsych.2016.08.005","article-title":"Anxiety symptoms in survivors of critical illness: a systematic review and meta-analysis","volume":"43","author":"Nikayin","year":"2016","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.jcrc.2026.155558_bb0015","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1097\/CCM.0000000000001811","article-title":"Depressive symptoms after critical illness: a systematic review and meta-analysis","volume":"44","author":"Rabiee","year":"2016","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2026.155558_bb0020","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/CCM.0000000000003547","article-title":"The effect of ICU diaries on psychological outcomes and quality of life of survivors of critical illness and their relatives: a systematic review and meta-analysis","volume":"47","author":"McIlroy","year":"2019","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2026.155558_bb0025","doi-asserted-by":"crossref","first-page":"R41","DOI":"10.1186\/cc10003","article-title":"Early intra-intensive care unit psychological intervention promotes recovery from post traumatic stress disorders, anxiety and depression symptoms in critically ill patients","volume":"15","author":"Peris","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.jcrc.2026.155558_bb0030","doi-asserted-by":"crossref","first-page":"e019998","DOI":"10.1136\/bmjopen-2017-019998","article-title":"Early rehabilitation to prevent postintensive care syndrome in patients with critical illness: a systematic review and meta-analysis","volume":"8","author":"Fuke","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.jcrc.2026.155558_bb0035","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.jcrc.2026.155558_bb0040","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/npp.2011.205","article-title":"Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior","volume":"37","author":"Haroon","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jcrc.2026.155558_bb0045","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/bcpt.12154","article-title":"The neuro-immune axis: prospect for novel treatments for mental disorders","volume":"114","author":"Kraneveld","year":"2014","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.jcrc.2026.155558_bb0050","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri.2015.5","article-title":"The role of inflammation in depression: from evolutionary imperative to modern treatment target","volume":"16","author":"Miller","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jcrc.2026.155558_bb0055","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","article-title":"Associations of depression with c-reactive protein, IL-1, and IL-6: a meta-analysis","volume":"71","author":"Howren","year":"2009","journal-title":"Psychosom Med"},{"key":"10.1016\/j.jcrc.2026.155558_bb0060","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jcrc.2026.155558_bb0065","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/jamapsychiatry.2014.1332","article-title":"Association of serum interleukin 6 and c-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study","volume":"71","author":"Khandaker","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jcrc.2026.155558_bb0070","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1038\/s41380-020-00867-4","article-title":"The longitudinal associations of inflammatory biomarkers and depression revisited: systematic review, meta-analysis, and meta-regression","volume":"26","author":"Mac Giollabhui","year":"2021","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.jcrc.2026.155558_bb0075","doi-asserted-by":"crossref","first-page":"7393","DOI":"10.1038\/s41380-021-01188-w","article-title":"Association of inflammation with depression and anxiety: evidence for symptom-specificity and potential causality from UK biobank and NESDA cohorts","volume":"26","author":"Milaneschi","year":"2021","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.jcrc.2026.155558_bb0080","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/mp.2016.167","article-title":"Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions","volume":"23","author":"Kappelmann","year":"2018","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.jcrc.2026.155558_bb0085","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","article-title":"A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers","volume":"70","author":"Raison","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jcrc.2026.155558_bb0090","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-025333","article-title":"Protocol for the insight study: a randomised controlled trial of single-dose tocilizumab in patients with depression and low-grade inflammation","volume":"8","author":"Khandaker","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.jcrc.2026.155558_bb0095","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/pcn.12820","article-title":"Inflammation and post-traumatic stress disorder","volume":"73","author":"Hori","year":"2019","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.jcrc.2026.155558_bb0100","doi-asserted-by":"crossref","first-page":"m3379","DOI":"10.1136\/bmj.m3379","article-title":"A living WHO guideline on drugs for covid-19","author":"Agarwal","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.jcrc.2026.155558_bb0105","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1056\/NEJMoa2100433","article-title":"Interleukin-6 receptor antagonists in critically ill patients with covid-19","volume":"384","author":"REMAP-CAP Investigators","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcrc.2026.155558_bb0110","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0140-6736(21)00676-0","article-title":"Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial","volume":"397","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jcrc.2026.155558_bb0115","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1001\/jama.2022.0040","article-title":"Clinical outcomes among patients with 1-year survival following intensive care unit treatment for COVID-19","volume":"327","author":"Heesakkers","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.jcrc.2026.155558_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2021.105295","article-title":"Interleukin-6 as potential mediator of long-term neuropsychiatric symptoms of COVID-19","volume":"131","author":"Kappelmann","year":"2021","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jcrc.2026.155558_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11481-020-09966-z","article-title":"Can cytokine blocking prevent depression in COVID-19 survivors?","volume":"16","author":"Benedetti","year":"2021","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1016\/j.jcrc.2026.155558_bb0130","doi-asserted-by":"crossref","first-page":"R125","DOI":"10.1186\/cc13929","article-title":"Long-term outcome of delirium during intensive care unit stay in survivors of critical illness: a prospective cohort study","volume":"18","author":"Wolters","year":"2014","journal-title":"Crit Care"},{"key":"10.1016\/j.jcrc.2026.155558_bb0135","doi-asserted-by":"crossref","first-page":"e018006","DOI":"10.1136\/bmjopen-2017-018006","article-title":"MONITOR-IC study, a mixed methods prospective multicentre controlled cohort study assessing 5-year outcomes of ICU survivors and related healthcare costs: a study protocol","volume":"7","author":"Geense","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.jcrc.2026.155558_bb0140","first-page":"100228","article-title":"Reduced fixed dose tocilizumab 400 mg IV compared to weight-based dosing in critically ill patients with COVID-19: a before-after cohort study","volume":"11","author":"Stukas","year":"2022","journal-title":"Lancet Reg Health - Am"},{"key":"10.1016\/j.jcrc.2026.155558_bb0145","author":"Stichting Werkgroep Antibioticabeleid (SWAB)"},{"key":"10.1016\/j.jcrc.2026.155558_bb0150","author":"Stichting Werkgroep Antibioticabeleid (SWAB)"},{"key":"10.1016\/j.jcrc.2026.155558_bb0155","author":"Stichting Werkgroep Antibioticabeleid (SWAB)"},{"key":"10.1016\/j.jcrc.2026.155558_bb0160","author":"World Health Organization"},{"key":"10.1016\/j.jcrc.2026.155558_bb0165","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1164\/rccm.201702-0372OC","article-title":"Core outcome measures for clinical research in acute respiratory failure survivors. An international modified Delphi consensus study","volume":"196","author":"Needham","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcrc.2026.155558_bb0170","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00127-009-0073-x","article-title":"Brief measure of posttraumatic stress reactions: impact of event scale-6","volume":"45","author":"Thoresen","year":"2010","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"10.1016\/j.jcrc.2026.155558_bb0175","series-title":"Assessing Psychological Trauma and PTSD","first-page":"399","article-title":"The impact of event scale - revised","author":"Weiss","year":"1996"},{"key":"10.1016\/j.jcrc.2026.155558_bb0180","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s13054-019-2553-z","article-title":"Screening for posttraumatic stress disorder in ARDS survivors: validation of the impact of event scale-6 (IES-6)","volume":"23","author":"Hosey","year":"2019","journal-title":"Crit Care"},{"key":"10.1016\/j.jcrc.2026.155558_bb0185","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1378\/chest.12-0908","article-title":"Posttraumatic stress disorder in survivors of acute lung injury: evaluating the impact of event scale-revised","volume":"144","author":"Bienvenu","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.jcrc.2026.155558_bb0190","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0022-3999(01)00296-3","article-title":"The validity of the hospital anxiety and depression scale. An updated literature review","volume":"52","author":"Bjelland","year":"2002","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.jcrc.2026.155558_bb0195","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1513\/AnnalsATS.201808-564PS","article-title":"Control of confounding and reporting of results in causal inference studies. Guidance for authors from editors of respiratory, sleep, and critical care journals","volume":"16","author":"Lederer","year":"2019","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jcrc.2026.155558_bb0200","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1164\/rccm.202009-3381OC","article-title":"New physical, mental, and cognitive problems 1 year after ICU admission: a prospective multicenter study","volume":"203","author":"Geense","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcrc.2026.155558_bb0205","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jointm.2022.02.002","article-title":"Health-related quality of life and stress-related disorders in COVID-19 ICU survivors: are they worse than with other causes of ARDS?","volume":"2","author":"Gil","year":"2022","journal-title":"J Intensive Med"},{"key":"10.1016\/j.jcrc.2026.155558_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2020.06.002","article-title":"Psychotropic medication use in former ICU patients with mental health problems: a prospective observational follow-up study","author":"Janssen","year":"2020","journal-title":"J Crit Care"},{"key":"10.1016\/j.jcrc.2026.155558_bb0215","series-title":"Incorporating Repeatedly Measured Predictor Data in Prediction Models for Intensive Care Unit Outcome","author":"Soliman","year":"2018"},{"key":"10.1016\/j.jcrc.2026.155558_bb0220","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1097\/00003246-200107000-00012","article-title":"Evaluation of delirium in critically ill patients: validation of the confusion assessment method for the intensive care unit (CAM-ICU)","volume":"29","author":"Ely","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2026.155558_bb0225","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s001340100909","article-title":"Intensive care delirium screening checklist: evaluation of a new screening tool","volume":"27","author":"Bergeron","year":"2001","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2026.155558_bb0230","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/s00134-022-06725-x","article-title":"Systemic glucocorticoid use during ICU admission and symptoms of posttraumatic stress disorder in intensive care unit survivors","volume":"48","author":"van Gelder","year":"2022","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2026.155558_bb0235","series-title":"R: A Language and Environment for Statistical Computing [Internet]","author":"R Core Team","year":"2024"},{"key":"10.1016\/j.jcrc.2026.155558_bb0240","author":"Wickham"},{"key":"10.1016\/j.jcrc.2026.155558_bb0245","author":"Wickham"},{"key":"10.1016\/j.jcrc.2026.155558_bb0250","author":"Wickham"},{"key":"10.1016\/j.jcrc.2026.155558_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v040.i03","article-title":"Dates and times made easy with {lubridate}","volume":"40","author":"Grolemund","year":"2011","journal-title":"J Stat Softw"},{"key":"10.1016\/j.jcrc.2026.155558_bb0260","author":"Wickham"},{"key":"10.1016\/j.jcrc.2026.155558_bb0265","author":"Rich"},{"key":"10.1016\/j.jcrc.2026.155558_bb0270","author":"Gohel"},{"key":"10.1016\/j.jcrc.2026.155558_bb0275","author":"Gohel"},{"key":"10.1016\/j.jcrc.2026.155558_bb0280","series-title":"ggplot2: Elegant Graphics for Data Analysis","author":"Wickham","year":"2016"},{"key":"10.1016\/j.jcrc.2026.155558_bb0285","series-title":"Psych: Procedures for Psychological, Psychometric, and Personality Research","author":"Revelle","year":"2024"},{"key":"10.1016\/j.jcrc.2026.155558_bb0290","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1056\/NEJM200005183422002","article-title":"Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation","volume":"342","author":"Kress","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcrc.2026.155558_bb0295","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1164\/rccm.200303-455OC","article-title":"The long-term psychological effects of daily sedative interruption on critically ill patients","volume":"168","author":"Kress","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcrc.2026.155558_bb0300","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/CCM.0000000000001419","article-title":"The effect of dexamethasone on symptoms of posttraumatic stress disorder and depression after cardiac surgery and intensive care admission","volume":"44","author":"Kok","year":"2016","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2026.155558_bb0305","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s10067-014-2609-z","article-title":"Responsiveness of the EuroQol EQ-5D and hospital anxiety and depression scale (HADS) in rheumatoid arthritis patients receiving tocilizumab","volume":"33","author":"Traki","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jcrc.2026.155558_bb0310","first-page":"664","article-title":"Fatigue in rheumatoid arthritis: quantitative findings on the efficacy of tocilizumab and on factors associated with fatigue. The french multicentre prospective PEPS study","volume":"33","author":"Gossec","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jcrc.2026.155558_bb0315","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13268","article-title":"The impact of tocilizumab on anxiety and depression in patients with rheumatoid arthritis","volume":"50","author":"Tiosano","year":"2020","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jcrc.2026.155558_bb0320","doi-asserted-by":"crossref","first-page":"551","DOI":"10.55563\/clinexprheumatol\/yu55rd","article-title":"Characterisation of depressive symptoms in rheumatoid arthritis patients treated with tocilizumab during routine daily care","volume":"40","author":"Behrens","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jcrc.2026.155558_bb0325","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-020-01164-y","article-title":"The IL-6 antagonist tocilizumab is associated with worse depression and related symptoms in the medically ill","volume":"11","author":"Knight","year":"2021","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.jcrc.2026.155558_bb0330","article-title":"Long-term cognitive performance and its relation to anti-inflammatory therapy in a cohort of survivors of severe COVID-19","volume":"25","author":"Duindam","year":"2022","journal-title":"Brain Behav Immun Health"},{"key":"10.1016\/j.jcrc.2026.155558_bb0335","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/02537176221140557","article-title":"Depression, anxiety, and quality of life in patients treated with single infusion tocilizumab for COVID-19: a follow-up, controlled study","volume":"45","author":"Chakravarty","year":"2023","journal-title":"Indian J Psychol Med"},{"key":"10.1016\/j.jcrc.2026.155558_bb0340","doi-asserted-by":"crossref","first-page":"11738","DOI":"10.1038\/s41598-024-62505-1","article-title":"Tocilizumab is associated with reduced delirium and coma in critically ill patients with COVID-19","volume":"14","author":"Alkhateeb","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcrc.2026.155558_bb0345","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1097\/CCM.0000000000001861","article-title":"Long-term mental health problems after delirium in the ICU*","volume":"44","author":"Wolters","year":"2016","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2026.155558_bb0350","first-page":"447","article-title":"Convergent validity of measures of post-traumatic stress disorder in a mixed military and civilian population","volume":"7","author":"Neal","year":"1994","journal-title":"J Trauma Stress"},{"key":"10.1016\/j.jcrc.2026.155558_bb0355","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jpsychores.2010.04.006","article-title":"The hospital anxiety and depression scale: a diagnostic meta-analysis of case-finding ability","volume":"69","author":"Brennan","year":"2010","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.jcrc.2026.155558_bb0360","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1007\/s00134-003-1763-6","article-title":"Quality of life on admission to the intensive care: can we query the relatives?","volume":"29","author":"Hofhuis","year":"2003","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2026.155558_bb0365","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/CCM.0b013e318265f340","article-title":"Quality of life before intensive care using EQ-5D","volume":"41","author":"Dinglas","year":"2013","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2026.155558_bb0370","doi-asserted-by":"crossref","DOI":"10.1093\/gerona\/glaf132","article-title":"Symptom trajectories after COVID hospitalization and risk factors for symptom burden in older persons: a longitudinal cohort study","author":"Pan","year":"2025","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jcrc.2026.155558_bb0375","doi-asserted-by":"crossref","DOI":"10.1093\/gerona\/glae092","article-title":"Associations of social support with physical and mental health symptom burden after COVID-19 hospitalization among older adults","volume":"79","author":"Lee","year":"2024","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jcrc.2026.155558_bb0380","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1056\/NEJMoa2403211","article-title":"Postacute sequelae of SARS-CoV-2 infection in the Pre-Delta, delta, and omicron eras","volume":"391","author":"Xie","year":"2024","journal-title":"N Engl J Med"}],"container-title":["Journal of Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088394412600136X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088394412600136X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T02:44:35Z","timestamp":1780454675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088394412600136X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":76,"alternative-id":["S088394412600136X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcrc.2026.155558","relation":{},"ISSN":["0883-9441"],"issn-type":[{"value":"0883-9441","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association between interleukin-6 inhibitors as treatment for COVID-19 and mental health problems in ICU survivors","name":"articletitle","label":"Article Title"},{"value":"Journal of Critical Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcrc.2026.155558","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"155558"}}